IMAC Regeneration Centers (BACK) - Market Cap to Earnings

Corporate emblem and logo of IMAC Regeneration Centers (BACK)

This chart illustrates that the market value of IMAC Holdings, Inc. (BACK) is fixed at -0.20. The business is betting on the expansion of joint and spine recovery centers, combining physiotherapy with non-invasive treatment methods. Financial stability relies on government support and a steady client flow, while staff optimization in favor of management has enabled effective control of existing capital.

IMAC Corp - BACK Price to Earnings Ratio (period 02/21/2024 - 12/31/2024)

Analytical breakdowns for IMAC Holdings, Inc.

- stock value and consensus price forecast:
Stock Quotes IMAC Holdings|BACK - Analyst Consensus Forecast
- market capitalization indicators:
Market Value IMAC Regeneration Centers|BACK - Total Company Value
- book value of equity indicators:
Equity per Share IMAC Holdings|BACK - Company Net Assets|Market Cap to Book Value Multiple imacholdings.comm|BACK - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Coefficient IMAC Holdings, Inc.|BACK - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio IMAC Holdings, Inc.|BACK - Company Aggregate Debts|Debts to Book Capitalization IMAC Holdings Inc|BACK - Company Long-Term Debts|Company Current Liabilities IMAC Holdings|Intermediate Coverage Ratio imacholdings.comm
- financial results and valuation multiples details:
BACK - Net Profit|Expected Net Income IMAC Holdings, Inc.|BACK - Price to Earnings Ratio|Projected Price to Earnings Ratio IMAC Corp|BACK - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMAC Holdings Inc|BACK - Operating profit EBITDA|Earnings per share for the last 12 months IMAC Holdings|BACK - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months imacholdings.comm|BACK - Earnings per share growth in current year|Projected earnings per share growth rate for next year IMAC Holdings, Inc.
- issuer revenue and sales details:
BACK - Revenue and Sales Volume|Company Sales Forecast IMAC Holdings Inc|BACK - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio IMAC Corp
Summary company analysis:BACK, IMAC Holdings
Manufactured product of IMAC Holdings, Inc.

Investors seek to minimize the risk of overpaying for an asset amid volatility. Stable demand for regenerative medicine services and regenerative technologies at IMAC Holdings, Inc. (BACK) creates a foundation for business valuation. The current price-to-earnings ratio compares market capitalization with net income, determining the cost of one dollar of profit. Analyzing this metric allows for the identification of overvalued shares relative to the actual cash flows of the clinics. Rational monitoring of this metric prevents investment in undervalued but stagnating assets.

Key competitors

Market Cap to Earnings hcahealthcare.com HCA|Price to Earnings Ratio Tenet Healthcare (THC)|Fresenius Medical Care - Price to Earnings Multiple|Price to Earnings Ratio Solventum SOLV|Market Price to Net Income Ratio EHC (Encompass Health)|UHS: Price to Earnings Ratio|DVA (DaVita) - Price to Earnings Multiple|RadNet Corp (RDNT) - Price to Earnings Ratio|Market Cap to Earnings Option Care Corp (OPCH)|Price to Earnings Ratio SGRY|PINC: Company Value to Net Income|P/E Multiple EYE|PGNY - Market Cap to Earnings|P/E Multiple ARDT (ardenthealth.com)|SEM - Price to Earnings Ratio|Astrana Corp - P/E Multiple|Company Value to Net Income MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Price to Earnings Ratio|Market Cap to Earnings Pennant Group (PNTG)|ORGO (Organogenesis Holdings Inc.) - P/E Multiple|NUTX: Company Value to Net Income|P/E Multiple AUNA|Price to Earnings Ratio SBC Medical Group Holdings Inc SBC|Price to Earnings Ratio Jeuveau EOLS|Company Value to Net Income CYH|SKIN: Price to Earnings Ratio|Company Value to Net Income MDWD (MediWound)|BTMD (biote.com) - Price to Earnings Ratio|Price to Earnings Ratio thejoint.com|DCGO (DocGo, Inc.) - P/E Multiple|Price to Earnings Ratio PIII|Price to Earnings Ratio GANX (Gain Therapeutics Inc.)|P/E Multiple EUDA Health (EUDA)|Basel Medical Group - Price to Earnings Ratio|Market Price to Net Income Ratio CLGN (CollPlant Ltd)|cuprina.com.sg - P/E Multiple|Company Value to Net Income CCM (Concord Medical Services Holdings)|AMS: P/E Multiple|Market Cap to Earnings MEDIROM Corp (MRM)|ALBT (Avalon GloboCare Corporation) - P/E Multiple|Price to Earnings Multiple DHAI (DIH Holding US, Inc.)|P/E Multiple XAGE|Business Payback Period NewGenIvf Group|Price to Earnings Ratio ATI Physical Therapy Inc. ATIP|CareMax Medical Group (CMAX) - Market Cap to Earnings|KDLY - Price to Earnings Ratio|Company Value to Net Income MODV (ModivCare Inc.)|Novo Integrated (NVOS) - Price to Earnings Ratio|SSY - Business Payback Period